Structural Biology and Molecular Modeling Market Size, Share, Growth, Trends, and Global Industry Analysis: By Tools (SaaS and Standalone Modeling, Visualization and Analysis, and Other Tools), By Application (Drug Development, Drug Discovery, and Other Applications), and Region Forecast 2020-2031

Structural biology and molecular modeling market size was valued at US$ 9,177.5 million in 2024 and is expected to reach US$ 26,410.8 million by 2031, growing at a significant CAGR of 16.3% from 2025-2031. Structural biology investigates the molecular structure of biological macromolecules such as proteins and nucleic acids, providing essential insight into the biological mechanisms that sustain life. Technological advancements, such as virtual reality and software, have the potential to change the drug research industry. Protein is the primary focus of structural biologists due to its importance in the body.

They investigate the functioning of molecules and how they respond to create new life. All drug design firms are working on modeling projects to better understand the structure of freshly developed medications so that they can bid on them. People's poor lifestyles these days contribute to an increase in chronic idiopathic constipation treatment illness instances. The growing senior population in wealthy nations raises the incidence of chronic illnesses such as diabetes and cancer. This structural biology and molecular modeling are useful in the medical and healthcare sectors since it aids in the discovery of cures for a variety of disorders.

Increased investment in R&D by pharmaceutical companies will boost this industry since it will result in valuable discoveries that will provide solutions to many incurable diseases. The emergence of new diseases, such as coronavirus and Ebola, might potentially push this industry in the future. The government is working hard and promoting research and pharmaceutical companies to enhance medical quality. But, they are also imposing severe laws to govern the research and pharmaceutical companies, requiring them to follow the criteria so that in developing and producing better quality and outcomes, they do not jeopardies other things.

Key Developments:

In July 2022, Cadence Design Systems Inc acquired Open Eye Scientific Software inc to leverage Cadence's computational software expertise in molecular modelling and simulation.